Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.
Recommended Citation
Rahbar H, Karabon P, Menon M, Trinh QD, and Abdollah F. Trends in prostate-specific antigen screening since the implementation of the 2012 US preventive services task force recommendations. Eur Urol Focus 2017; 4(6):1002-1004.
Document Type
Article
Publication Date
12-1-2018
Publication Title
Eur Urol Focus
Abstract
In 2012, the US Preventive Services Task Force recommended against prostate-specific antigen (PSA) screening. Following the initial decrease in PSA screening rate, there appears to be no further decrease in screening rate from 2013 to 2015. In addition, the screening rate did not differ by age or race.
Medical Subject Headings
Advisory Committees; African Americans; Aged; Asian Americans; Early Detection of Cancer; Ethnic Groups; European Continental Ancestry Group; Hispanic Americans; Humans; Kallikreins; Logistic Models; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Preventive Health Services; Prostate-Specific Antigen; Prostatic Neoplasms; United States
PubMed ID
28753856
Volume
4
Issue
6
First Page
1002
Last Page
1004
